Cargando…
Characterization of anti-factor VIII antibody in a patient with acquired hemophilia A
Acquired hemophilia A (AHA) is a bleeding disorder caused by the development of an auto-antibody against endogenous factor VIII (FVIII). In this study, the epitope of the autoantibody was identified in a 67-year-old female patient with AHA. A prolonged activated partial thromboplastin time (77.4 s)...
Autores principales: | Oh, Jisu, Lim, Yeongmin, Jang, Moon Ju, Huh, Ji Young, Shima, Midori, Oh, Doyeun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624998/ https://www.ncbi.nlm.nih.gov/pubmed/23589798 http://dx.doi.org/10.5045/br.2013.48.1.58 |
Ejemplares similares
-
A case of transfusion-related acute lung injury induced by anti-human leukocyte antigen antibodies in acute leukemia
por: Jin, Sun Mi, et al.
Publicado: (2012) -
Postpartum Acquired Hemophilia Factor VIII Inhibitors and Response to Therapy
por: Karakuş, Volkan, et al.
Publicado: (2012) -
Idiopathic Acquired Hemophilia A with Undetectable Factor VIII Inhibitor
por: Abt, Nicholas B., et al.
Publicado: (2014) -
Long-term course of anti-factor VIII antibody in patients with hemophilia A at a single center
por: Yoo, Ki Young, et al.
Publicado: (2016) -
Bispecific Antibodies and Advances in Non–Gene Therapy Options in Hemophilia
por: Shima, Midori
Publicado: (2020)